Next-Generation Sequencing (NGS) Market Revenue 2024 to 2034
Next-Generation Sequencing (NGS) Market Revenue 2024 to 2034
The NGS market will surge from USD 10.27 Bn in 2024 to USD 73.47 Bn by 2034, at a 21.75% CAGR, supported by precision medicine, genomics research, and falling sequencing costs enabling wider clinical applications.
Report ID: 10664
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 10.27 Bn
Forecast Year,
USD 73.47 Bn
CAGR, 2025 -
21.75%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Next-Generation Sequencing (NGS) Market Size Analysis
Next-Generation Sequencing (NGS) Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | 0.20 | 0.23 | 0.27 | 0.45 | 0.34 | 0.21 | 1.04 | 1.40 | 1.53 | 1.55 | 1.74 |
| Platforms | 8.74 | 10.65 | 12.94 | 15.85 | 19.15 | 23.39 | 27.74 | 34.77 | 42.87 | 49.95 | 63.09 |
| Services | 1.33 | 1.62 | 2.02 | 2.23 | 3.07 | 3.87 | 4.67 | 4.55 | 5.17 | 8.84 | 8.64 |
Next-Generation Sequencing (NGS) Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sequencing by Synthesis | 3.32 | 4.04 | 4.93 | 5.95 | 7.32 | 8.62 | 11.39 | 12.78 | 15.62 | 19.46 | 26.23 |
| Ion Semiconductor | 3.37 | 4.07 | 5.11 | 6.11 | 7.22 | 8.91 | 10.74 | 13.66 | 16.85 | 19.49 | 24.44 |
| Single-molecule Real-time | 2.92 | 3.52 | 4.32 | 5.36 | 6.50 | 7.69 | 9.44 | 11.77 | 13.68 | 16.00 | 18.14 |
| Others | 0.67 | 0.87 | 0.86 | 1.10 | 1.53 | 2.25 | 1.86 | 2.50 | 3.42 | 5.39 | 4.66 |
Next-Generation Sequencing (NGS) Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics | 1.27 | 1.59 | 1.83 | 2.15 | 2.97 | 3.75 | 4.03 | 5.44 | 5.63 | 7.38 | 9.11 |
| Oncology Biomarker | 3.75 | 4.56 | 5.61 | 6.77 | 7.97 | 9.72 | 12.64 | 15.34 | 18.40 | 22.01 | 28.31 |
| Reproductive Health | 4.09 | 4.95 | 6.05 | 7.48 | 9.01 | 10.98 | 12.62 | 15.98 | 20.33 | 22.89 | 30.10 |
| Others | 1.16 | 1.41 | 1.74 | 2.14 | 2.61 | 3.02 | 4.14 | 3.95 | 5.21 | 8.06 | 5.95 |
Next-Generation Sequencing (NGS) Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Academic & Research | 2.41 | 2.93 | 3.62 | 4.30 | 5.29 | 6.85 | 7.64 | 9.21 | 11.26 | 13.49 | 16.11 |
| Hospitals & Clinics | 4.43 | 5.39 | 6.48 | 8.04 | 9.76 | 11.54 | 14.57 | 17.54 | 21.19 | 25.33 | 31.70 |
| Pharma & Biotech | 3.43 | 4.18 | 5.12 | 6.19 | 7.52 | 9.08 | 11.23 | 13.96 | 17.12 | 21.53 | 25.67 |
Next-Generation Sequencing (NGS) Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.79 | 3.44 | 4.11 | 5.05 | 6.22 | 7.24 | 9.10 | 11.57 | 13.06 | 15.60 | 19.53 |
| Europe | 1.02 | 1.22 | 1.47 | 1.52 | 2.26 | 2.70 | 3.79 | 4.86 | 5.50 | 3.85 | 5.89 |
| Asia Pacific | 2.98 | 3.62 | 4.44 | 5.53 | 6.51 | 7.98 | 9.36 | 11.11 | 13.53 | 19.15 | 21.93 |
| Latin America | 1.71 | 2.08 | 2.53 | 3.30 | 3.82 | 5.00 | 5.35 | 6.23 | 8.33 | 8.82 | 12.26 |
| Middle East & Africa | 1.78 | 2.14 | 2.67 | 3.13 | 3.74 | 4.55 | 5.83 | 6.95 | 9.16 | 12.93 | 13.85 |
Next-Generation Sequencing (NGS) Market
Next-Generation Sequencing (NGS) Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
